Skip to search.

Breaking News Visit Yahoo! News for the latest.

×Close this window

 Dow Down 0.52% Nasdaq Down 1.11%
Streaming
Ticker Tape: On

Galectin Therapeutics, Inc. (GALT)

-NasdaqCM

4.18 May 22, 4:00PM EDT

Add to Portfolio
Prev Close:4.18
Open:N/A
Bid:3.76 x 1000
Ask:4.82 x 200
1y Target Est:7.00
Beta:2.03
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.60 - 5.22
Volume:0
Avg Vol (3m):90,810
Market Cap:67.93M
P/E (ttm):N/A
EPS (ttm):-0.77
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for GALT

Comparison

Symbol% ChgMkt Cap
GALT 0.00%67.93M
DRREDDY.NSDown 0.21%348.42B
DRREDDY.BODown 0.27%348.35B
HIK.LDown 1.37%1.91B
DIVISLAB.BODown 1.44%130.12B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-13) :-0.69
Quarterly EPS Est (Jun-13) :-0.17
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Galectin Therapeutics Inc., a development stage company, engages in the development of therapies for cancer and fibrotic disease. Its lead product candidates include GR-MD-02, a complex polysaccharide polymer for the treatment of liver fibrosis an... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback